FindTrial
Sign In

The effect of clomiphene citrate on clinical outcome in Progestin-Primed Ovarian Stimulation using Dydrogesterone in normalovulatory women

The effect of clomiphene citrate on clinical outcome in Progestin-Primed Ovarian Stimulation using Dydrogesterone in normalovulatory women

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015619
Enrollment
Unknown
Registered
2018-04-12
Start date
2018-04-10
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

HMG+Dydrogesterone:HMG+Dydrogesterone
HMG+Dydrogesterone+CC:HMG+Dydrogesterone+CC

Sponsors

Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: According to the WHO standards, the diagnosis of infertility; B-FSH less than 10IU/L; Aged younger than 40 years; Normal menstrual cycle24-35 days;Antral follicle counts more than 5; Did not receive any reproductive hormone drugs for nearly three months.

Exclusion criteria

Exclusion criteria: PCOS, endometrosis grade 3 or higher, documented ovarian failure, and any contraindications to ovarian stimulation treatment.

Design outcomes

Primary

MeasureTime frame
the number of oocyte retrieved;—

Secondary

MeasureTime frame
LH value;Progesterone value;HMG consumption per oocyte retrieval;number of viable embryos;incidence of premeture LH;—

Contacts

Public ContactKuang Yanping

Shanghai Nineth People's Hospital

kuangyanp@126.com+86 021-53078108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026